Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

Stopped early

Conditions studied: Melanoma

In brief

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

Key facts

Study ID

NCT02339987

Run by

Saint John's Cancer Institute

People needed

27

Starts

2014-11-01

Expected to finish

2018-06-04

Last updated by the study team

2019-02-21

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have metastatic melanoma with a resectable metastasis who are undergoing resection for palliation, therapeutic or curative purpose.
• Patients must be > 15 years of age and must have metastatic melanoma.
• Patients must meet standard pre-operative requirements as determined by the surgeon to be candidates for surgery.
• Patients must be able to understand and sign the Informed Consent document.
• Patients must be able to complete the supplemental data form

You may not qualify if…

• women who are pregnant or breastfeeding
• inability to give consent

Where it is running

• John Wayne Cancer Institute — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.